AP NEWS

4th Biomarker and Companion Diagnostics Conference (San Diego, United States - February 7-8, 2019) - ResearchAndMarkets.com

December 19, 2018

DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Biomarker and Companion Diagnostics Conference” conference has been added to ResearchAndMarkets.com’s offering.

Biomarker is constantly evolving as the latent for the development of innovative drugs and diagnostic assays for early detection of disease. Major developments have been seen in immune therapies where breakthroughs will be appearing soon.

The 4th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 7th-8th February 2019 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

Key Highlights

Clinical biomarker identification and qualification Biomarkers and personalized medicine Assay development and validation NGS and novel technologies in biomarker discovery Commercialization of biomarkers in therapeutic and CDx applications

Why Attend

30+ experts from academia and industry presenting their current work in Biomarkers Latest updates on regulatory guidelines and approvals Case studies from experts who have successfully created and developed a biomarker Facilitated networking sessions to ensure quality interactions One on one query handling by biomarker experts Opportunity to develop long-lasting business relationships and networking opportunities with senior peers

Who Should Attend:

Researchers, scientists, clinicians, academicians and professionals from

Pharmaceutical companies Bio-pharma companies Universities and Research institutes

Working in:

Biomarker discovery/development Translational research Clinical Biomarker Biomarkers in IO and Neurological disorders Imaging Biomarkers Pathology Companion Diagnostics

For more information about this conference visit https://www.researchandmarkets.com/research/xkjhgz/4th_biomarker_and?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005570/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biomarkers

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/19/2018 11:43 AM/DISC: 12/19/2018 11:43 AM

http://www.businesswire.com/news/home/20181219005570/en

AP RADIO
Update hourly